Jim Cramer compares NFL playoff teams to stock picks
CNBC’s Jim Cramer on Friday compared all NFL 14 teams competing in the playoffs to some of his top stock picks. “As I was reviewing this weekend’s slate of six …
Johnson & Johnson
J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on …
Jim Cramer examines the Dow’s best and worst performers of 2023
CNBC’s Jim Cramer on Tuesday broke down the five best and worst performers on the Dow Jones Industrial Average during 2023. Cramer compared each Dow company’s closing price in 2022 …
Only 2 are in the Magnificent Seven
It was a big rebound year for stocks. The S & P 500 gained 24%, while the Dow rose 14% and the tech-heavy Nasdaq rose more than 43%. All three …
Investor Michael Farr is back with his top 10 stocks he’s buying for 2024, and the tilt is defensive
Traders work on the floor of the New York Stock Exchange (NYSE) on the first day back since the Christmas holiday on December 26, 2023 in New York City. Spencer …
Medicare drug price negotiations what’s ahead in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker …
Stock buying and selling strategies into year end
During the December Monthly Meeting , we took questions directly from Investing Club members. Here are Jim Cramer’s and Director of Portfolio Analysis Jeff Marks’ responses. Their answers have been …
Big Pharma takes on counterfeit drugs
In Las Vegas, Lazaro Hernandez was a flamboyant, jet-setting poker player shown in televised tournaments with stacks of colorful chips. But the casually dressed gambler spotted on security cameras with …
Biden administration asserts power to seize drug patents
President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a visit to OB Johnson Park and Community Center, in Hallandale Beach, Florida, on Nov. …
Jim Cramer explains why it’s hard to be bullish on healthcare
CNBC’s Jim Cramer on Thursday told investors why it’s hard to be bullish about healthcare stocks, citing challenges stemming from government action and lack of innovation. “We could really use …